Form 4: Michael Berman Reports Share Transactions in InspireMD, Inc.

Director Michael Berman reports acquisition and disposal of InspireMD, Inc. shares, including restricted stock and options.

Summary

• On January 7, 2025, Michael Berman, a director of InspireMD, Inc., reported transactions involving the company's common stock.
• Berman acquired 32,491 shares of common stock at $0, representing restricted stock that will vest on January 7, 2026, contingent upon continued service.
• He also disposed of 183,746 shares held indirectly through the Michael Berman Revocable Trust; this transaction is for informational purposes only.
• Additionally, Berman acquired options to purchase 14,836 shares of common stock at an exercise price of $2.71, which will vest on January 7, 2026, subject to continued service.
• Following these transactions, Berman directly owns 264,533 shares of common stock and 84,950 options, and indirectly owns 183,746 shares through the trust.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard reporting of insider transactions. The acquisition of shares and options could be seen as a slightly positive sign, but the disposal of shares in trust is for informational purposes only.

Positives

• The acquisition of restricted stock and options could indicate confidence in the company's future performance.

Future Outlook

The vesting of restricted stock and options is contingent upon the Reporting Person's continued service.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors.

Stakeholder Impact

• The transactions may influence investor perception of the company's stock.

Key Dates